These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12476956)

  • 1. ACH-126443 Achillion/Yale University.
    Patel J; Mitra AK
    Curr Opin Investig Drugs; 2002 Nov; 3(11):1580-4. PubMed ID: 12476956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New nucleoside reverse transcriptase inhibitors for the treatment of HIV infections.
    Otto MJ
    Curr Opin Pharmacol; 2004 Oct; 4(5):431-6. PubMed ID: 15351346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zalcitabine (Hivid).
    Res Initiat Treat Action; 2000 Mar; 6(1):10-1. PubMed ID: 11708175
    [No Abstract]   [Full Text] [Related]  

  • 4. ViroLogic announces agreement with Achillion.
    Pharmacogenomics; 2002 Mar; 3(2):163. PubMed ID: 11981960
    [No Abstract]   [Full Text] [Related]  

  • 5. TMC-125 Tibotec.
    Haslinger BA; Arendt G
    Curr Opin Investig Drugs; 2004 Feb; 5(2):208-13. PubMed ID: 15043396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Zalcitabine].
    Enferm Infecc Microbiol Clin; 1997 Mar; 15(3):177-8. PubMed ID: 9235070
    [No Abstract]   [Full Text] [Related]  

  • 7. A review of entecavir in the treatment of chronic hepatitis B infection.
    Rivkin A
    Curr Med Res Opin; 2005 Nov; 21(11):1845-56. PubMed ID: 16307706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating the effects of stereochemistry on incorporation and removal of 5-fluorocytidine analogs by mitochondrial DNA polymerase gamma: comparison of D- and L-D4FC-TP.
    Murakami E; Ray AS; Schinazi RF; Anderson KS
    Antiviral Res; 2004 Apr; 62(1):57-64. PubMed ID: 15026203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV Pathogenesis and Treatment - Third International AIDS Society Conference.
    Susman E
    IDrugs; 2005 Oct; 8(10):813-5. PubMed ID: 16254799
    [No Abstract]   [Full Text] [Related]  

  • 10. Viramidine (Ribapharm).
    Barnard D
    Curr Opin Investig Drugs; 2002 Nov; 3(11):1585-9. PubMed ID: 12476957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunodeficiency and new treatment for HBV.
    Benhamou Y
    Nurs Stand; 1995 Mar 1-7; 9(23):14. PubMed ID: 7703142
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of chronic hepatitis B in HIV co-infected patients.
    Guan R
    Med J Malaysia; 2005 Jul; 60 Suppl B():52-6. PubMed ID: 16108174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir.
    Sheldon J; Camino N; Rodés B; Bartholomeusz A; Kuiper M; Tacke F; Núñez M; Mauss S; Lutz T; Klausen G; Locarnini S; Soriano V
    Antivir Ther; 2005; 10(6):727-34. PubMed ID: 16218172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of long-term suppression of hepatitis B virus DNA by tenofovir as rescue treatment in patients coinfected by HIV.
    Quiros-Roldan E; Calabresi A; Lapadula G; Tirelli V; Costarelli S; Cologni G; Zaltron S; Puoti M; Carosi G; Torti C
    Antivir Ther; 2008; 13(3):341-8. PubMed ID: 18572746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug insight: Nucleoside and nucleotide analog inhibitors for hepatitis B.
    Fung SK; Lok AS
    Nat Clin Pract Gastroenterol Hepatol; 2004 Dec; 1(2):90-7. PubMed ID: 16265070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lamivudine: a magic bullet for chronic hepatitis B?
    Grimm I
    Gastroenterology; 1996 Jul; 111(1):262-4. PubMed ID: 8698214
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug evaluation: LB-80380--a novel phosphonate nucleoside for the potential treatment of HBV infection.
    Papatheodoridis GV; Manolakopoulos S
    Curr Opin Mol Ther; 2006 Aug; 8(4):352-7. PubMed ID: 16955699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel nonnucleoside inhibitors that select nucleoside inhibitor resistance mutations in human immunodeficiency virus type 1 reverse transcriptase.
    Zhang Z; Walker M; Xu W; Shim JH; Girardet JL; Hamatake RK; Hong Z
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2772-81. PubMed ID: 16870771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of HIV drug resistance to nucleoside and nucleotide reverse transcriptase inhibitors.
    Geretti AM
    AIDS Rev; 2006; 8(4):210-20. PubMed ID: 17219736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rilpivirine, a non-nucleoside reverse transcriptase inhibitor for the treatment of HIV infection.
    Ripamonti D; Maggiolo F
    Curr Opin Investig Drugs; 2008 Aug; 9(8):899-912. PubMed ID: 18666038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.